UPDATE: MLV & Co Raises PT On Halozyme Therapeutics On Promising Start To 2015
January 08, 2015 at 09:36 AM EST
In a report published Thursday, MLV & Co analyst Arlinda Lee reiterated a Buy rating on Halozyme Therapeutics (NASDAQ: HALO), and raised ...